1. Dr. Lal Path Labs
stock logo

63% Sell

Dr. Lal Path Labs Share Price

LALPATHLAB

₹2,358.40+₹54.10 (2.35%) Past Year
₹2,309.95₹2,392.45
L
Show Current Price
H
  • News

  • Company overview

  • Fundamentals

  • Events

  • F&O (Option chain)

  • More

Company overview

About

arrow

Market cap

Market Cap Switch₹19,156 Cr

Open

₹2,309.95

Close

₹2,304.30

Circuit range

₹2,534.70 - ₹2,073.90

Day range

₹2,309.95 - ₹2,392.45

Year range

₹1,848.05 - ₹2,767.10

Volume

6,66,769

Avg. traded

₹2,366.32

Revenue (12m)

₹2,172 Cr

Dr. Lal Path LabsDr. Lal PathLabs Limited is an India-based company that is engaged in providing diagnostic and related healthcare tests and services. The Company is engaged in the business of running laboratories for carrying out pathological investigations of various branches of biochemistry, hematology, histopathology, microbiology, electrophoresis, immuno-chemistry, immunology, virology, cytology, and other pathological and radiological investigations. It offers a range of tests by condition, which includes allergy, diabetes, health checkups, viral infections, fever, heart diseases, hypertension, cancer, abortions, anemia, arthritis, breast cancer, diphtheria, disorder of the liver, disorders of bone, drugs of abuse, infertility, lymphoma, tuberculosis, ovarian cancer, osteoporosis, multiple sclerosis, muscular disorder, and viral infections. The Company’s subsidiaries include Paliwal Diagnostics Private Limited, Paliwal Medicare Private Limited, and Dr. Lal PathLabs Nepal Private Limited.

Read more

Dr. Lal Path Labs Key indicators

arrow

52 week high

₹2,767.10

52 week low

₹1,848.05

P/E ratio

59.52

P/B ratio

10.62

ROE

19.19%

ROCE

22.71%

Dividend yield

0.51%

Debt/Equity ratio

0.15

EPS

35.07

Learn more

Investment checklist: (5/6)

arrow
check status

Equity returns

check status

Dividend returns

check status

Safety factor

check status

Growth factor

check status

Debt vs Equity

check status

Profit factor

The investment checklist helps you understand a company's financial health at a glance and identify quality investment opportunities easily

Analyst ratings:

Sell

arrow

Buy

25%

Hold

12%

Sell

63%

This analysis is based on the reviews of 16 experts in the last 7 days

Fundamentals

Financial ratios

arrow
  • Profitability

  • Operational

  • Valuation

Operating profit margin

28.68%

Net profit margin

16.53%

ROE

19.19%

ROA

13.09%

ROCE

22.71%

Learn more

Dr. Lal Path Labs Shareholder returns

arrow

1 day

+0.69%

1 week

+0.55%

1 month

+5.75%

3 months

-7.90%

1 year

+24.48%

3 years

-26.54%

5 years

+125.88%

Revenue statement

All values are in ₹ Crores (Cr)
arrow
Empty state

No data available at the moment

Cash flow

All values are in ₹ Crores (Cr)
arrow
Empty state

No data available at the moment

Balance sheet

All values are in ₹ Crores (Cr)
arrow
Empty state

No data available at the moment

Dr. Lal Path Labs Share Price history

arrow
DayOpenCloseDay’s change
Fri, Apr 12 2024
₹2,309.95
₹2,358.40
+2.05%
Wed, Apr 10 2024
₹2,290.00
₹2,304.30
+0.62%
Tue, Apr 9 2024
₹2,290.80
₹2,288.60
-0.10%
Mon, Apr 8 2024
₹2,284.90
₹2,290.80
+0.26%
Fri, Apr 5 2024
₹2,252.45
₹2,284.30
+1.39%
Thu, Apr 4 2024
₹2,309.95
₹2,276.70
-1.46%
Wed, Apr 3 2024
₹2,289.90
₹2,291.60
+0.07%
Tue, Apr 2 2024
₹2,303.00
₹2,278.15
-1.09%

Shareholding info

arrow

Promoters (54.6%)

Mutual Funds (5.88%)

Retail and other (10.49%)

Foreign institutions-FII (25.36%)

Other domestic institutions (3.67%)

Promoters

Learn more

Events

Corporate actions

arrow
  • Dividend • ₹12/share

    Ex date 13 Feb 2024

    expand tab
  • Dividend • ₹6/share

    Ex date 11 Aug 2023

    expand tab
  • Dividend • ₹6/share

    Ex date 11 Aug 2023

    expand tab
  • Dividend • ₹6/share

    Ex date 05 Aug 2022

    expand tab
  • Dividend • ₹6/share

    Ex date 22 Jun 2022

    expand tab

Learn more

Frequently asked questions